4/12
08:01 am
imab
I-Mab (NASDAQ: IMAB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
Low
Report
I-Mab (NASDAQ: IMAB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
4/5
07:14 am
imab
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Low
Report
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
4/5
07:00 am
imab
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference
Low
Report
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference
4/2
04:04 pm
imab
I-Mab Announces Closing of the Divestiture of Business Operations in China [Yahoo! Finance]
Low
Report
I-Mab Announces Closing of the Divestiture of Business Operations in China [Yahoo! Finance]
4/2
04:01 pm
imab
I-Mab Announces Closing of the Divestiture of Business Operations in China
Low
Report
I-Mab Announces Closing of the Divestiture of Business Operations in China
3/18
02:53 pm
imab
I-Mab (NASDAQ: IMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock, down previously from $18.00.
Low
Report
I-Mab (NASDAQ: IMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock, down previously from $18.00.
3/18
02:52 pm
imab
I-Mab (NASDAQ: IMAB) had its price target lowered by analysts at Piper Sandler from $15.00 to $10.00. They now have an "overweight" rating on the stock.
Low
Report
I-Mab (NASDAQ: IMAB) had its price target lowered by analysts at Piper Sandler from $15.00 to $10.00. They now have an "overweight" rating on the stock.
3/18
07:02 am
imab
I-Mab Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
I-Mab Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
3/14
05:09 pm
imab
I-Mab Reports Full Year 2023 Financial Results and Business Update [Yahoo! Finance]
Medium
Report
I-Mab Reports Full Year 2023 Financial Results and Business Update [Yahoo! Finance]
3/14
05:00 pm
imab
I-Mab Reports Full Year 2023 Financial Results and Business Update
Medium
Report
I-Mab Reports Full Year 2023 Financial Results and Business Update
2/18
03:43 am
imab
I-Mab: Trading Below Net Cash With Multiple Upside Options [Seeking Alpha]
Medium
Report
I-Mab: Trading Below Net Cash With Multiple Upside Options [Seeking Alpha]
2/8
03:37 pm
imab
I-Mab (NASDAQ: IMAB) had its price target lowered by analysts at Needham & Company LLC from $23.00 to $8.00. They now have a "buy" rating on the stock.
Low
Report
I-Mab (NASDAQ: IMAB) had its price target lowered by analysts at Needham & Company LLC from $23.00 to $8.00. They now have a "buy" rating on the stock.
2/7
09:09 am
imab
Biotech firm I-Mab to divest China operations, shift focus to US [Reuters]
Medium
Report
Biotech firm I-Mab to divest China operations, shift focus to US [Reuters]
2/7
06:47 am
imab
I-Mab to Divest Chinese Unit for Up to $80M [MarketWatch]
Medium
Report
I-Mab to Divest Chinese Unit for Up to $80M [MarketWatch]
2/7
06:13 am
imab
I-Mab Signs Agreement to Divest its Assets and Business Operations in China [Yahoo! Finance]
Medium
Report
I-Mab Signs Agreement to Divest its Assets and Business Operations in China [Yahoo! Finance]
2/7
06:00 am
imab
I-Mab Signs Agreement to Divest its Assets and Business Operations in China
Low
Report
I-Mab Signs Agreement to Divest its Assets and Business Operations in China